These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11737386)

  • 1. Antiretroviral treatment of central nervous system HIV-1 infection: a review.
    Gisslén M; Hagberg L
    HIV Med; 2001 Apr; 2(2):97-104. PubMed ID: 11737386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.
    Yilmaz A; Verhofstede C; D'Avolio A; Watson V; Hagberg L; Fuchs D; Svennerholm B; Gisslén M
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):590-6. PubMed ID: 20847699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.
    Cinque P; Bestetti A; Morelli P; Presi S
    J Neurovirol; 2000 May; 6 Suppl 1():S95-S102. PubMed ID: 10871772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of multidrug resistance in the central nervous system.
    McCarty EJ; Quah SP; Dinsmore WW; Emerson CR
    Int J STD AIDS; 2010 Nov; 21(11):777-9. PubMed ID: 21187362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid analysis in the HIV infection and compartmentalization of HIV in the central nervous system.
    Almeida SM
    Arq Neuropsiquiatr; 2015 Jul; 73(7):624-9. PubMed ID: 26200059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.
    Letendre S; Marquie-Beck J; Capparelli E; Best B; Clifford D; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Morgello S; Simpson D; Grant I; Ellis RJ;
    Arch Neurol; 2008 Jan; 65(1):65-70. PubMed ID: 18195140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.
    de Almeida SM; Rotta I; Ribeiro CE; Oliveira MF; Chaillon A; de Pereira AP; Cunha AP; Zonta M; Bents JF; Raboni SM; Smith D; Letendre S; Ellis RJ
    J Neurovirol; 2017 Jun; 23(3):460-473. PubMed ID: 28247269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.
    Yilmaz A; Fuchs D; Hagberg L; Nillroth U; Ståhle L; Svensson JO; Gisslén M
    BMC Infect Dis; 2006 Mar; 6():63. PubMed ID: 16566834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection.
    Abdulle S; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
    AIDS; 2002 Nov; 16(16):2145-9. PubMed ID: 12409735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
    García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
    AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration.
    Eggers C; Hertogs K; Stürenburg HJ; van Lunzen J; Stellbrink HJ
    AIDS; 2003 Sep; 17(13):1897-906. PubMed ID: 12960822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurologic complications of HIV disease and their treatment.
    Letendre SL; Ellis RJ; Ances BM; McCutchan JA
    Top HIV Med; 2010; 18(2):45-55. PubMed ID: 20516524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
    Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
    Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.
    Marra CM; Zhao Y; Clifford DB; Letendre S; Evans S; Henry K; Ellis RJ; Rodriguez B; Coombs RW; Schifitto G; McArthur JC; Robertson K;
    AIDS; 2009 Jul; 23(11):1359-66. PubMed ID: 19424052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.
    Canestri A; Lescure FX; Jaureguiberry S; Moulignier A; Amiel C; Marcelin AG; Peytavin G; Tubiana R; Pialoux G; Katlama C
    Clin Infect Dis; 2010 Mar; 50(5):773-8. PubMed ID: 20100092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
    Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
    HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNS as an HIV-1 reservoir; BBB and drug delivery.
    Kerza-Kwiatecki AP; Amini S
    J Neurovirol; 1999 Apr; 5(2):113-4. PubMed ID: 10321974
    [No Abstract]   [Full Text] [Related]  

  • 18. CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose.
    Calcagno A; Barco A; Trunfio M; Bonora S
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):84-91. PubMed ID: 29363025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roundtable report: importance of antiretroviral drug concentrations in sanctuary sites and viral reservoirs.
    Reddy YS; Kashuba A; Gerber J; Miller V;
    AIDS Res Hum Retroviruses; 2003 Mar; 19(3):167-76. PubMed ID: 12689408
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV in Cerebrospinal Fluid and Central Nervous System.
    Pazare AR
    J Assoc Physicians India; 2017 Aug; 65(8):11-12. PubMed ID: 28799298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.